|
|
H2016/CTD4571/718
|
BERGCLIN 300
|
CLINDAMYCIN CAPSULES BP 300MG
|
SYNER-MED PHARMACEUTICALS (K)LTD
|
Registered
|
Details →
|
|
|
H2022/CTD10232/22679
|
FIRIALTA 10 MG TABLET
|
FINERENONE
|
BAYER EAST AFRICA LTD
|
Registered
|
Details →
|
|
|
H2009/19598/168
|
CABERLINE 0.5MG TABLETS
|
CABERGOLINE
|
SUN PHARMA EAST AFRICA LTD
|
Registered
|
Details →
|
|
|
H2009/19598/168/R1
|
CABERLINE 0.5MG TABLETS
|
Cabergoline
|
Sun Pharmaceutical Industries Limited
|
Retained
|
Details →
|
|
|
H2022/CTD10415/22720
|
IXAROLA 10MG FILM-COATED TABLET
|
RIVAROXABAN
|
BAYER EAST AFRICA LTD
|
Registered
|
Details →
|
|
|
H2022/CTD10400/22721
|
IXAROLA 15MG FILM-COATED TABLET
|
RIVAROXABAN
|
BAYER EAST AFRICA LTD
|
Registered
|
Details →
|
|
|
H2022/CTD9905/21293
|
VERQUVO 10MG
|
VERICIGUAT
|
BAYER EAST AFRICA LTD
|
Registered
|
Details →
|
|
|
16833
|
LNG IUS
|
LEVONORGESTREL
|
BAYER EAST AFRICA LTD
|
Registered
|
Details →
|
|
|
H2010/16833/R1
|
LNG IUS
|
Levonorgestrel
|
Bayer AG
|
Retained
|
Details →
|
|
|
H2022/CTD10231/22743
|
FIRIALTA 20 MG TABLET
|
FINERENONE
|
BAYER EAST AFRICA LTD
|
Registered
|
Details →
|
|
|
H2022/CTD9903/21030
|
VERQUVO 2.5 MG
|
VERICIGUAT
|
Withdrawn Voluntarily by Market Authorization Holder for Commercial reasons only. Withdrawal is not due to quality and safety issues.
|
|
Details →
|
|
|
H2022/CTD9904/21378
|
VERQUVO 5MG
|
VERICIGUAT
|
BAYER EAST AFRICA LTD
|
Registered
|
Details →
|
|
|
H2022/CTD10395/22722
|
IXAROLA 20MG FILM-COATED TABLET
|
RIVAROXABAN
|
BAYER EAST AFRICA LTD
|
Registered
|
Details →
|
|
|
H2018/CTD4527/481ER
|
PRILIGY 30MG
|
DAPOXETINE
|
PHILLIPS PHARMACEUTICALS LTD
|
Registered
|
Details →
|
|
|
H2019/CTD4528/482ER
|
PRILIGY 60MG
|
DAPOXETINE HYDROCHLORIDE
|
PHILLIPS THERAPEUTICS LIMITED
|
Registered
|
Details →
|
|
|
CTD4528
|
PRILIGY
|
DAPOXETINE
|
PHILLIPS THERAPEUTICS LIMITED
|
Registered
|
Details →
|
|
|
H2012/CTD546/352
|
XARELTO
|
RIVAROXABAN
|
BAYER EAST AFRICA LTD
|
Registered
|
Details →
|